TATVANSETatva Chintan Pharma Chem LimitedMinimalNeutral
Announced Fri, 29 May · 12:26 IST

Shekhar Rasiklal Somani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.0%1-day move
₹1150.00
prior close
₹1159.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.5+0.5+0.0+3.0+5.9+5.7+3.4+4.3+1.2+3.9+3.7
Up moveDown movePending
AI summary

Promoter Shekhar Rasiklal Somani has submitted a declaration to BSE and NSE confirming that neither he nor any persons acting in concert (PAC) have created any encumbrance (pledge) on the company's shares during the Financial Year ended 31 March 2026. The declaration covers 13 entities in the promoter group including family members and related companies. This is a mandatory regulatory filing under SEBI's takeover regulations to disclose share pledging activities by promoters.

Likely market impact

A positive disclosure for shareholders as it confirms promoters have not pledged their shares, reducing risk of potential forced selling pressure. This indicates promoter confidence in the company's prospects.